NYSE
$17.33▼ 0.86%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $6.19BShares out 3.600M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
19- 10.13Pre-market26.10.13 19:098-KKey event#●●●#●●●
Bausch & Lomb Corp
Bausch + Lomb announced that CEO Brent Saunders will step down effective October 12, 2026, and appointed Board Chairman Thomas J. Appio as interim CEO. Alongside this leadership change, the company expects to raise its full-year 2026 guidance for adjusted EBITDA excluding Acquired IPR&D.…more
$17.33-0.86%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.28Regular26.09.29 04:10144Ownership
Bausch & Lomb Corp
Karen Ling, an insider at Bausch & Lomb Corp, has filed an SEC Form 144 to report a proposed sale of company shares. This filing serves as a formal notification of the executive's plan to divest a portion of their holdings.…more
$17.33-0.86%vs prev closeView filingShare - 8.12After-hours26.08.13 08:064Ownership
Bausch & Lomb Corp
Bausch & Lomb Corp insider Frederick Munsch reported changes in his beneficial ownership of securities as of August 10, 2026. This filing serves as an official disclosure of the insider's equity position changes to the SEC.…more
$17.33-0.86%vs prev closeView filingShare
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 5d agoRegular26.10.20 03:46#●●●#●●●#●●●
Billionaire Dan Loeb Takes Stake in Bausch + Lomb Amid CEO Transition
Activist investor Dan Loeb has acquired a stake in Bausch + Lomb as the company appoints a new interim CEO and raises its 2026 EBITDA guidance. However, the company faces challenges including an FDA warning letter and mixed results from recent clinical trials.…more
$17.33-0.86%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 10.12Regular26.10.13 03:13
●●●●●●●● ●●●●● ●●●●●●
Bausch + Lomb shares fell nearly 10% after the company announced the departure of CEO Brent Saunders and the appointment of Thomas J. Appio as interim CEO. Despite the company signaling an increase in full-year earnings guidance, the sudden leadership transition triggered investor uncertainty.…more
$17.33-0.86%vs prev closeShareBenzinga - 10.12Pre-market26.10.12 19:48
●●●●●●●● ●●●●● ●●●●●●
Bausch + Lomb has appointed Thomas J. Appio as interim CEO and announced plans to raise its 2026 adjusted EBITDA guidance. The company will provide further details during its third-quarter earnings report on October 28.…more
$17.33-0.86%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report